S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

NVS

Novartis (NVS)

Novartis AG

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:NVS

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
05/07/2024	6:00AM	GlobeNewswire Inc.	Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update	NYSE:NVS	Novartis AG
04/23/2024	6:25AM	IH Market News	Apple Loses Market Share in China, GM Surges in Pre-Market Following Upward Revisions for 2024 Projections, and More News	NYSE:NVS	Novartis AG
04/15/2024	1:00PM	PR Newswire (US)	New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)	NYSE:NVS	Novartis AG
04/11/2024	6:00AM	GlobeNewswire Inc.	Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer	NYSE:NVS	Novartis AG
04/10/2024	6:13AM	IH Market News	Delta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More News	NYSE:NVS	Novartis AG
04/06/2024	3:16PM	PR Newswire (US)	New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting	NYSE:NVS	Novartis AG
02/15/2024	3:15PM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NYSE:NVS	Novartis AG
02/06/2024	3:52PM	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NYSE:NVS	Novartis AG
02/06/2024	5:14AM	IH Market News	Boeing Faces Strike Threat, Palantir Up 18% After Recording its First Profitable Year, and More	NYSE:NVS	Novartis AG
02/05/2024	4:06PM	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NYSE:NVS	Novartis AG
02/02/2024	1:18PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:NVS	Novartis AG
01/31/2024	6:44AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVS	Novartis AG
01/31/2024	6:43AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVS	Novartis AG
01/31/2024	6:42AM	Edgar (US Regulatory)	Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).	NYSE:NVS	Novartis AG
01/31/2024	6:38AM	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NYSE:NVS	Novartis AG
01/31/2024	5:28AM	IH Market News	Walmart’s Stock Split, Elon Musk’s Billion-Dollar Package Revoked, and More	NYSE:NVS	Novartis AG
01/22/2024	12:59AM	Dow Jones News	Sandoz to Acquire Cimerli Business from Coherus for $170 Million	NYSE:NVS	Novartis AG
01/12/2024	5:10AM	IH Market News	Wall Street Highlights: DocuSign Acquisition Battle, Tesla Berlin Production Halt, and More	NYSE:NVS	Novartis AG
01/11/2024	12:02PM	Dow Jones News	Cytokinetics Shares Slide as Novartis Reportedly Shies Away From Deal	NYSE:NVS	Novartis AG
01/08/2024	12:43PM	Dow Jones News	Cytokinetics Shares Jump 16% After WSJ Report of Novartis Deal	NYSE:NVS	Novartis AG
01/08/2024	9:41AM	Dow Jones News	Novartis on Track for Record High Close -- Data Talk	NYSE:NVS	Novartis AG
01/08/2024	5:13AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVS	Novartis AG
01/08/2024	1:01AM	Dow Jones News	Novartis's Scemblix Drug Meets Main Goals in Late-Stage Leukemia Trial	NYSE:NVS	Novartis AG
01/05/2024	9:15AM	Dow Jones News	Novartis to Make Pluvicto Radioligand Therapy at Indianapolis Plant	NYSE:NVS	Novartis AG
01/02/2024	6:46AM	Dow Jones News	Voyager Therapeutics Shares Leap Premarket on Novartis Collaboration	NYSE:NVS	Novartis AG
12/11/2023	5:05AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:NVS	Novartis AG
12/11/2023	1:02AM	Dow Jones News	Novartis Drug Meets Primary Goal in Late-Stage Study for Kidney Disease	NYSE:NVS	Novartis AG
12/10/2023	6:39PM	PR Newswire (US)	Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)	NYSE:NVS	Novartis AG
12/06/2023	4:14AM	Dow Jones News	Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials	NYSE:NVS	Novartis AG
12/05/2023	11:18PM	PR Newswire (US)	Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH	NYSE:NVS	Novartis AG

Showing the most relevant articles for your search:NYSE:NVS

1 2 3 4 5 6 7 8 9 10 Next >>

Plandai Biotechnology (PK)

Global Developments (PK)

Greenwave Technology Sol...

Ronn Motor (PK)

Faraday Future Intellige...

Mike The Pike Productions (CE)

Yuenglings Ice Cream (PK)

1812 Brewing (PK)

CTR Investments and Cons... (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions